Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment
Mehri Monavarian, Amal Elhaw, Priscilla W. Tang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 709-719
Open Access | Times Cited: 18

Showing 18 citing articles:

Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Yuqi Yang, Tianjiao Zhao, Qiaohui Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 28
Open Access | Times Cited: 40
Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis
Li Han, Shuling Xu, Dongqi Zhou, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 10
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer
Zainab Shonibare, Mehri Monavarian, Kathleen O’Connell, et al.
Cell Reports (2022) Vol. 40, Iss. 4, pp. 111066-111066
Open Access | Times Cited: 32
Immunotherapy for Ovarian Cancer: Disappointing or Promising?
Mengqi Deng, Fan Tang, Xiangyu Chang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 454-466
Closed Access | Times Cited: 8
Identification and validation of anoikis-related lncRNAs for prognostic significance and immune microenvironment characterization in ovarian cancer
Lixue Cao, Shaofen Zhang, Haojie Peng, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1463-1483
Open Access | Times Cited: 3
Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
Jingfang Wang, Wenrui Zhu, Xia Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Icariside II induces ferroptosis through the down-regulation of SLC7A11 in ovarian cancer
Donglan Yuan, Ting Guo, Xiaotong Zhu, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins
Diana Luísa Almeida-Nunes, Ricardo Silvestre, Ricardo Jorge Dinis‐Oliveira, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 323-323
Open Access | Times Cited: 9
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types
Meetu Rathee, Sheikh Mohammad Umar, Arundhathi Dev, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Visualization of tumor-associated neutrophils in malignant ascites of ovarian cancer with aptamer-decorated AIE probes
Jing Wang, Xiaona Fang, Jiezhen Yang, et al.
Sensors and Actuators B Chemical (2024) Vol. 405, pp. 135385-135385
Closed Access | Times Cited: 2
Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance
Huiran Yue, Xin Lü
Acta Biochimica et Biophysica Sinica (2023)
Open Access | Times Cited: 6
Insights into the tumor-stromal-immune cell metabolism cross talk in ovarian cancer
Priscilla W. Tang, Leonard Frisbie, Nadine Hempel, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 3, pp. C731-C749
Closed Access | Times Cited: 5
Strain and hyaluronic acid interact to regulate ovarian cancer cell proliferation, migration, and drug resistance
Maranda Kramer, Allyson Criswell, Kamari Marzette, et al.
Mechanobiology in Medicine (2024) Vol. 2, Iss. 4, pp. 100094-100094
Open Access | Times Cited: 1
A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents
Leilei Guo, Xiaokang Qin, Liting Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX models
Daniele Boso, Ilaria Piga, Chiara Trento, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access
Editorial: Role of chemokines in tumor heterogeneity
Jawed A. Siddiqui, Mohd W. Nasser
Seminars in Cancer Biology (2023) Vol. 92, pp. 128-129
Closed Access
Significance of Ascites Cytology in Early Diagnosis of the Nature of Ovarian Malignancy
梦珂 聂
Advances in Clinical Medicine (2023) Vol. 13, Iss. 04, pp. 6496-6501
Closed Access
Progress in the Treatment of Peritoneal Metastatic Cancer and the Application of Therapeutic Nanoagents
Wenjun Dai, Yidan Chen, Yunxin Xue, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 11, pp. 4518-4548
Closed Access
Page 1

Scroll to top